Currently, there are no portable methods that can spot assess oxygenation (hypoxia) of microvasculature. Clinical systems are either expensive, inacessible or impresise in measurements of tissue oxygenation.
Utilizes photoacoustic technology to assess functional information using point-of-care ultrasound hardware, enabling physicians with rapid, real-time measurements of tissue oxygenation.
PA probe is currently in the research and development phase and not available for sale in any country.
The PA probe allows physicians an instant spot-assessment of deep tissue oxygenation, allowing sensitive real-time measurement of hypoxia or early stage ischemia.
With competitive pricing to other point-of-care ultrasound systems, the PA probe allows easy assessment of hypoxia reduces healthcare costs, demonstrate effectiveness of therapies and reduce complications.
The PA probe is a solution that provides patients a peace of mind as their physicians are empowered with critical clinical indicators.
We collaborate with leading healthcare institutions and technology partners to advance point-of-care diagnostics.
Top-tier hospitals and clinics driving clinical validation
Academic partners advancing tissue assessment science
Industry leaders in optical sensing and medical devices
Startup accelerators and innovation hubs